Trials / Completed
CompletedNCT01568723
Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation
Stem Cells And The Origins Of Barrett's Esophagus:Identification Of Novel Biomarkers And Gene Signatures In Barrett's Esophagus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 125 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine biomarkers which can predict response to ablation therapy in patients with Barretts esophagus.
Detailed description
This Project is designed to identify biologically-based and clinically-useful biomarkers of tissue at risk for neoplastic progression as well as of response to ablation therapy. These results will result in improved risk stratification in BE and better targeting of resources for patients who are candidates for ablative therapy, while simultaneously providing key information regarding the origins of Barrett's esophagus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | response to therapy | evaluate specific markers for response to therapy at specific intervals pre and post therapy |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2018-08-16
- Completion
- 2018-08-16
- First posted
- 2012-04-02
- Last updated
- 2021-12-15
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01568723. Inclusion in this directory is not an endorsement.